Log In
BCIQ
Print this Print this
 

SP20202

  Manage Alerts
Collapse Summary General Information
Company Sarfez Pharmaceuticals Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today